Tag
Talzenna
-
FDA Approves Pfizer’s Talzenna Combo for HRR-Mutated Metastatic Prostate Cancer
Pfizer’s PARP inhibitor plus enzalutamide is now approved for HRR-mutated metastatic prostate cancer before resistance sets in. In TALAPRO-3 it cut the…
Tag
Pfizer’s PARP inhibitor plus enzalutamide is now approved for HRR-mutated metastatic prostate cancer before resistance sets in. In TALAPRO-3 it cut the…